Asensus Surgical

Asensus Surgical Debt

Delisted

Debt of Asensus Surgical (ASXC) as of Oct 22, 2026.

Debt

0.00USD

Last updated:

In 2023, Asensus Surgical's total debt was 0.00 USD, a % change from the 0.00 USD total debt recorded in the previous year.

The Asensus Surgical Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2016
13.00 M USD
Jan 1, 2017
13.20 M USD
Jan 1, 2018
28.90 M USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
2.80 M USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
The Asensus Surgical Debt history
YEARDebtYoY
0.00USD—
0.00USD—
0.00USD-100.00%
2.80 MUSD—
0.00USD-100.00%
28.90 MUSD+118.94%
13.20 MUSD+1.54%
13.00 MUSD-34.01%
19.70 MUSD+101.02%
9.80 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Asensus Surgical Stock analysis

What does Asensus Surgical do? Asensus Surgical Inc is a medical technology company based in Research Triangle Park, North Carolina, USA. It was founded in 1995 by Joe Mussallem, who still serves as President and CEO today. Formerly known as "TransEnterix," the company changed its name to Asensus Surgical Inc in 2021 to reflect its commitment to advanced, data-driven surgery. Asensus Surgical Inc aims to revolutionize the way surgical procedures are performed by utilizing robotic technology and offering a wide range of products and services. The company's business model is based on transferring skills typically held by surgeons to robots, with a focus on precision in surgeries. Through the use of machine learning and computer vision, Asensus Surgical Inc allows surgeons to monitor their own movements in real-time on robotic arms in the operating room, leading to significantly more precise work. The company's main division is the Senhance® Surgical System platform. The system consists of three components: the artificial intelligence technology of the Intelligent Surgical Units (ISU), touchscreen consoles, and a further sterilization cabinet. During surgical procedures, the Intelligent Surgical Units process real-time data, enabling improved decision-making during the operation. The touchscreen consoles serve as the user interface, allowing surgeons to monitor and control the operation in real-time on a screen. The sterilization cabinet ensures that the system is sterilized between procedures. In addition to the Senhance® Surgical System platform, Asensus Surgical Inc also offers other innovative products such as disposable instruments. This includes "3-mm instruments," special miniature instruments that can be used through very small incisions in the patient's body. These minimize scarring and enable faster recovery. Another product offered by Asensus Surgical Inc is the AI Camera Assistant, which is based on artificial intelligence (AI). This is a computer software that supports surgeons by analyzing real-time images and enabling monitoring and analysis during the procedure. Combined with the Senhance® Surgical System, the AI Camera Assistant allows for more precise and safer work. Asensus Surgical Inc has achieved several significant milestones in its history. One of these milestones is the FDA approval of the Senhance® Surgical System platform in 2017. Furthermore, in 2020, the company entered into an agreement with Johnson & Johnson to advance the marketing of products. Overall, Asensus Surgical Inc is an emerging company in the highly innovative field of robotics in surgery. With its advanced products and focus on precise, safe, and straightforward surgery, the company will continue to play an important role in the healthcare industry, saving and improving lives. Asensus Surgical is one of the most popular companies on Eulerpool.

Debt Details

Understanding Asensus Surgical's Debt Structure

Asensus Surgical's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Asensus Surgical's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Asensus Surgical’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Asensus Surgical’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Asensus Surgical stock

On Eulerpool you can find the complete historical development of Debt Asensus Surgical since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Asensus Surgical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Asensus Surgical

All Key Metrics — Asensus Surgical